{"id":23,"date":"2024-06-08T17:40:34","date_gmt":"2024-06-08T08:40:34","guid":{"rendered":"http:\/\/evermed.jp\/?page_id=23"},"modified":"2024-08-07T17:56:49","modified_gmt":"2024-08-07T08:56:49","slug":"home","status":"publish","type":"page","link":"http:\/\/evermed.jp\/?page_id=23","title":{"rendered":"HOME"},"content":{"rendered":"\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column has-white-color has-white-background-color has-text-color has-background has-link-color wp-elements-6188f540a1e8b3b30123f9ca1169031b is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"has-text-align-center has-background wp-block-paragraph\" style=\"background-color:#235f61;font-size:40px;font-style:normal;font-weight:800\"><strong><em>EVerMed<\/em><\/strong><\/p>\n\n\n\n<p class=\"has-text-align-center has-white-color has-text-color has-background has-link-color wp-elements-cfa05100953aa6aa2f0cfa15daf6e1ad wp-block-paragraph\" style=\"background-color:#34546e;font-size:24px;font-style:normal;font-weight:800\"><strong><em>Realizing everlasting medical treatment through therapeutic use of extracellular vesicles (EVs)<\/em><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\">EverMed Inc. is a biotech startup founded based on the research of Dr. Yu Fujita of the Department of Respiratory Medicine and Next-Generation Drug Discovery Research at the Jikei University School of Medicine (Tokyo Japan) on the use of extracellular&nbsp;vesicles (EVs) to treat intractable respiratory diseases.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">It is estimated that there are more than 1 billion patients worldwide who suffer from respiratory diseases such as lung cancer, asthma, COPD, and interstitial pneumonia. For example, about 2 million people die from lung cancer, about 3.3 million from COPD, and more than 1 million people die each year from various interstitial pneumonias and acute respiratory distress syndrome (ARDS) caused by infectious diseases such as COVID-19. However, there are still insufficient treatments for these respiratory diseases.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">To address these unmet medical needs, we are focusing on the use of EVs, a natural homeostatic mechanism in the human body, and are trying to create new treatments that address the root causes of diseases, including the inhibition of cellular aging.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>EVerMed Realizing everlasting medical treatment through therapeutic use of extracellular vesicles (EVs) EverMed Inc. is a biotech startup founded based on the research of Dr. Yu Fujita of the Department of Respiratory Medicine and Next-Generation Drug Discovery Research at the Jikei University School of Medicine (Tokyo Japan) on the use [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-23","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"http:\/\/evermed.jp\/index.php?rest_route=\/wp\/v2\/pages\/23","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/evermed.jp\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/evermed.jp\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/evermed.jp\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/evermed.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=23"}],"version-history":[{"count":9,"href":"http:\/\/evermed.jp\/index.php?rest_route=\/wp\/v2\/pages\/23\/revisions"}],"predecessor-version":[{"id":248,"href":"http:\/\/evermed.jp\/index.php?rest_route=\/wp\/v2\/pages\/23\/revisions\/248"}],"wp:attachment":[{"href":"http:\/\/evermed.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=23"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}